Login

Journal Front Page

News & Events

  • Call for article for January 2027 issue
  • Submissions of Review, Research Article, Short Communication and Case study are being accepted for the current and future issues before 15 December, 2026 of this journal by online process or editor@ajper.com, or ajper.editor@gmail.com. Further information can be found at www.ajper.com.
  • October 2026 Issue published
  • Dear Researcher, It Pleased to inform you that, Asian Journal of Pharmaceutical Education and Research, has successfully launch Volume 15, Issue 4 (October 2026 Issue). You can find the article on http://ajper.com/current_issue.php Article also invited for the Next coming Issue from your side. For More details Visit: www.ajper.com
  • Application For Reviewer
  • We are now going to reconstitute our editorial board members of Reviewer. Please send your resume at ajper.editor@gmail.com and be a part of the editorial board member as Reviewer.
  • AJPER Impact facor
  • It is to pleasure that Ajper SJIF imact facor has increse from 5.019 to 7.014. Also global impact factor incresed from 0.654 to 0.765.
  • ICV
  • AJPER Rank with Index Copernicus Value 61.10 due to high reputation at International Level

Abstract

DEVELOPMENT AND CHARACTERIZATION OF FAST DISSOLVING ORAL FILMS OF FENSPIRIDE HYDROCHLORIDE

Priyanka Ojha*, Dr. Satkar Prasad

RKDF School of Pharmaceutical Sciences, Bhabha University, NH-12, Jatkhedi, Hoshangabad Road, Bhopal- 462026

ABSTRACT

Fenspiride hydrochloride is a bronchodilator and anti-inflammatory agent used in respiratory disorders. Conventional oral formulations face challenges such as delayed onset of action and poor patient compliance, particularly in pediatric and geriatric populations. The present study aimed to develop and characterize fast dissolving oral films (FDOFs) of fenspiride hydrochloride to enhance patient acceptability, improve onset of action, and ensure uniform drug delivery. FDOFs were prepared using the solvent casting method with different concentrations of polymers and plasticizers. The films were evaluated for general appearance, thickness, weight, folding endurance, tensile strength, disintegration time, moisture content, drug content, and in-vitro drug release. The optimized formulation was subjected to stability studies over three months. All films were transparent with uniform thickness (52–72 µm) and weight (110–145 mg). Folding endurance ranged from 157–220, disintegration time from 28–70 seconds, tensile strength 0.64–0.78 kg/cm², and drug content 95.9–99.5%. The optimized formulation (F6) exhibited rapid drug release (98.85% in 10 min) and followed first-order release kinetics. Stability studies confirmed minimal drug degradation over three months. The optimized FDOFs of fenspiride hydrochloride demonstrated rapid disintegration, satisfactory mechanical properties, uniform drug content, and enhanced drug release, making them a promising dosage form for improving patient compliance and therapeutic efficacy in respiratory disorders.

Keywords: Fenspiride hydrochloride, Fast dissolving oral films, Solvent casting, Disintegration time, Drug release, Patient compliance.


[Full Text Article]